BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Beach

  Prometheus Laboratories Release: New Serum Test Is First to Measure and Monitor Mucosal Healing in Crohn’s Disease

  Prometheus Laboratories introduces a comprehensive new serum test that measures and monitors mucosal healing status in Crohn’s disease patients.

  October 16, 2017

   · 

  4 min read
• Drug Development

  Aptevo Therapeutics Showcases New Mechanism of Action for Its ADAPTIR Platform at the Inflammation Research Society Meeting

  New Autoimmune Candidate APVO210 Demonstrates Targeted Cytokine Delivery for Application in Various Autoimmune and Inflammatory Diseases.

  October 16, 2017

   · 

  9 min read
• Drug Development

  Celsion Announces Publication of the HEAT Study Manuscript in the High Impact Journal, Clinical Cancer Research

  The study was published in Clinical Cancer Research, a high impact, peer-reviewed medical journal.

  October 16, 2017

   · 

  11 min read
• Business

  Applied BioMath, LLC announces collaboration with Sanofi for quantitative systems pharmacology modeling in immuno-oncology

  Applied BioMath today announced a collaboration with Sanofi to develop QSP models in immuno-oncology.

  October 16, 2017

   · 

  2 min read
• Intellipharmaceutics Announces Closing of $4M Financing

  Intellipharmaceutics announced today the closing of its previously announced registered direct offering consisting of 3,636,364 common shares at a price of US$1.10 per share for gross proceeds of approximately US$4 million.

  October 16, 2017

   · 

  11 min read
• Ablynx’s Publication in Accordance With Article 14 of the Belgian Law of 2 May 2007 Regarding the Publication of Major Shareholdings (The “Transparency Law”)

  Ablynx received a notification of shareholdings from Consonance CapMan GP LLC on 11 October 2017.

  October 16, 2017

   · 

  4 min read
• Business

  Cerveau Technologies Signs Collaboration Agreement With Janssen For Novel Tau Imaging Agent

  Cerveau Technologies today announced a research collaboration agreement with Janssen Pharmaceuticals, Inc. for use of [F-18]MK-6240.

  October 16, 2017

   · 

  1 min read
• Drug Development

  BioAegis Hires Dr. Mark J. DiNubile as Chief Medical Officer to Spearhead Forthcoming Phase II Clinical Trials in Community-Acquired Pneumonia

  Dr. DiNubile brings to BioAegis the rare combination of clinical and research expertise along with broad pharmaceutical industry experience.

  October 16, 2017

   · 

  3 min read
• Drug Development

  Cara Therapeutics Announces Successful End-of-Phase II Meeting with FDA for I.V. CR845 in Chronic Kidney Disease-Associated Pruritus

  Cara, in consultation with the FDA, has established the key elements of the Phase 3 program to support a New Drug Application (NDA) for I.V. CR845.

  October 16, 2017

   · 

  5 min read
• BioMidwest

  Patients Battling Complex Regional Pain Syndrome Find A Host Of New Benefits In Abbott’s Proclaim DRG System

  Abbott today announced the U.S. launch of the company’s Proclaim DRG Neurostimulator System, a new device designed to deliver stimulation to the DRG and alleviate pain in patients suffering from CRPS of the lower limbs.

  October 16, 2017

   · 

  4 min read